CD70 (Protein|Antibody|cDNA Clone|ELISA Kit)

All CD70 reagents are produced in house and quality controlled, including 1 CD70 Antibody, 52 CD70 Gene, 6 CD70 Lysate, 6 CD70 Protein, 2 CD70 qPCR. All CD70 reagents are ready to use.

Recombinant CD70 proteins are expressed by HEK293 Cells with fusion tags as N-human IgG1-Fc, N-His, N-mouse IgG1-Fc, N-rabbit IgG-Fc.

CD70 antibodies are validated with different applications, which are WB.

CD70 cDNA clones are full length sequence confirmed and expression validated. There are 13 kinds of tags for each CD70 of different species, especially GFP tag, OFP tag, FLAG tag and so on. There are three kinds of vectors for choice, cloning vector, expression vector and lentivrial expression vector.

CD70 Protein (6)

Species

CD70 Protein, Mouse, Recombinant (Fc Tag)

51129-M04H

Expression host: HEK293 Cells

Mouse CD70/CD27L/TNFSF7 Protein 12109

CD70 Protein, Human, Recombinant (Fc Tag)

10780-H15H3

Expression host: HEK293 Cells

Human CD70/CD27L/TNFSF7 Protein 17875

CD70 Protein, Human, Recombinant (Fc Tag)

10780-H04H5

Expression host: HEK293 Cells

Human CD70/CD27L/TNFSF7 Protein 17847

CD70 Protein, Rat, Recombinant (Fc Tag)

80161-R01H

Expression host: HEK293 Cells

Rat CD70/CD27L/TNFSF7 Protein 12426

CD70 Protein, Rat, Recombinant (His Tag)

80161-R07H

Expression host: HEK293 Cells

Rat CD70/CD27L/TNFSF7 Protein 12427

CD70 Protein, Human, Recombinant (Fc Tag)

10780-H01H

Expression host: HEK293 Cells

Human CD70/CD27L/TNFSF7 Protein 9111
Go

CD70 Antibody (1)

Application
Clonality
Host

Anti-CD70 Antibody

101956-T32

Specificity: Mouse

Application: WB

Clonality: PAb

Mouse CD70/CD27L/TNFSF7 Western blot (WB) 14923
Go

CD70 cDNA Clone (52)

Human
Rat
Mouse
Rhesus

CD70 qPCR Primer (2)

CD70 Lysate (6)

CD7, a member of the tumor necrosis factor superfamily, is restricted to activated T-and B-lymphocytes and mature dendritic cells. Binding of CD7 to its receptor, CD27, is important in priming, effector functions, differentiation and memory formation of T-cells as well as plasma and memory B-cell generation. Tight control of CD7 expression is required to prevent lethal immunodeficiency. By selective transcription, CD7 is largely confined to activated lymphocytes and dendritic cells (DC). As a type II transmembrane receptor, CD7 is normally expressed on a subset of B, T and NK cells, where it plays a costimulatory role in immune cell activation. Immunohistochemical analysis of CD7 expression in multiple carcinoma types. The restricted expression pattern of CD7 in normal tissues and its widespread expression in various malignancies makes it an attractive target for antibody-based therapeutics. Investigations to exploit CD7 as a cancer target have lead to the identification of potential antibody-based clinical candidates.Immune Checkpoint
Immune Checkpoint Proteins
Immune Checkpoint Targets   Co-stimulatory Immune Checkpoint Targets Immunotherapy   Cancer Immunotherapy   Targeted Therapy
Protein
Antibody
Gene
qPCR
Lysate
Close